Our Network of Consultants

With over a decade of experience in Sales, Account Management, and Business Development across Europe, I bring a proven track record of growing revenue, structuring global sales operations, and managing complex biopharmaceutical relationships. My expertise spans both services and capital equipment (CAPEX) sales, with a consistent history of exceeding targets and closing multimillion-pound deals at executive level.

I currently operate as a Business Development and Sales Consultant for Cellevate AB and LiveDrop Bio, where I designed and implemented complete business development strategies, built CRM systems and performance dashboards, and positioned the companies among key academic and biopharma stakeholders. My recent achievements include generating leads and converting them into purchase orders through strong technical presentations and relationship-building with KOLs, CROs, and manufacturing partners.

Previously, as Global Key Account Manager at Miltenyi Biotec, I managed six global customers totaling 23 international sites, negotiated supply agreements, and developed multi-year growth strategies. I notably closed a £3.3 million CAPEX deal within two weeks and contributed €35 million toward the 2024 revenue plan. At Sartorius Stedim, I led high-value accounts across France, Benelux, and the UK, expanding revenue by more than 200% year-on-year while coordinating multi-site collaborations across R&D and manufacturing.

My career demonstrates a unique combination of scientific literacy and commercial strategy. I began in technical sales roles with Sartorius and BD, where I introduced innovative single-cell and flow cytometry technologies, managed market entry strategies, and won back blacklisted accounts through consultative negotiation. Over time, I transitioned into strategic sales leadership—defining go-to-market frameworks, establishing KPIs, and mentoring sales representatives across divisions and regions.

Fluent in both English and French, I excel in cross-cultural communication and high-level stakeholder engagement. My skill set spans consultative and strategic selling, global account mapping, contract negotiation, and profit planning. Equipped with deep knowledge of the biopharma value chain—from cell and gene therapy manufacturing to clinical and CDMO partnerships—I operate effectively within matrixed organizations and thrive in fast-evolving innovation environments.

Certified in advanced selling methodologies (Sandler, Miller Heiman, Mercuri) and completing PRINCE2 accreditation, I combine technical expertise, legal understanding, and business acumen to deliver sustainable commercial growth in the life sciences sector.

My area of study is the intersection of clinical neuroscience, translational pharmacology, and computational biomarker discovery. I am a PhD candidate investigating how glymphatic and meningeal–lymphatic pathways relate to neuroinflammation in humans. I focus on immune-cell phenotyping and cell-free markers that may index inflammatory activity and neurodegenerative trajectories. Alongside sampling development, I contribute to assay and workflow optimisation for mass-spectrometry-ready proteomics, with an emphasis on automation, quality control, and reproducibility.

My pharmacology and drug-safety foundation was built through an MRes in Biological Science and Translational Medicine. I examined dose- and time-dependent paracetamol-induced kidney injury in renal cell models, differentiating apoptotic and necrotic mechanisms and linking experimental readouts to clinically relevant nephrotoxicity questions. I completed a systematic review on cilastatin as a renoprotective strategy and critically evaluated in vitro acute kidney injury models for translational validity. I also gained ward-level exposure as a Clinical Research Associate in nephrology, aligning laboratory findings with real-world clinical pathways and multidisciplinary decision-making.

From an industry and communications perspective, I have experience in medical affairs-adjacent work, including market analysis to support launch planning in an ophthalmic pharmaceutical company and the development of compliant training materials with medical teams. I have delivered conference and hospital presentations, tailoring complex findings to both clinical and public audiences, and I have completed structured projects on European compliance frameworks, which underpins my approach to regulatorily aware medical writing.

Computationally, I build end-to-end machine-learning workflows in Python and R for noisy, high-dimensional datasets, particularly proteomics and multimodal clinical data. My toolkit spans supervised learning, unsupervised clustering, and dimensionality reduction.

Overall, my expertise is translating complex biomedical and quantitative evidence into actionable deliverables, supported by an MBA in Clinical Leadership and a strong biochemistry foundation, including earlier research on TEX12 expression in somatic and cancer models.

Physician | Clinical Scientist | Vaccine & Biologics Development

Physician and clinical scientist with over 15 years of international experience across the full spectrum of vaccine and biologics development, from early-phase innovation to late-phase clinical implementation. Currently serving as Clinical Science Lead at GSK Vaccines (Italy), providing strategic and scientific leadership for late-phase clinical trials in meningococcal disease and other vaccine-preventable infections.

My professional background includes early clinical development programs addressing antimicrobial resistance and neglected tropical diseases, with hands-on experience in monoclonal antibodies and innovative delivery strategies. I have contributed to more than 40 clinical trials across Latin America, Europe, and complex or conflict-affected settings, including investigator-initiated studies, the establishment of clinical research centers, and collaborations with global health organizations such as WHO and DNDi.

I hold formal training in epidemiology and global health, with solid regulatory experience interacting with FDA, EMA, and WHO frameworks. My work is guided by scientific rigor, operational excellence, and a strong commitment to public health impact.

I am particularly interested in the intersection of clinical development, data science, and digital innovation to improve clinical decision-making in immunology and translational medicine. I value cross-functional collaboration, ethical leadership, and mission-driven science, and I am always open to scientific exchange and global partnerships that advance equitable access to transformative health solutions.

During 16 years as a Ph.D. immunologist in the Life Science sector, I gained extensive expertise in the areas of inflammation/autoimmunity, immuno-oncology, MicroRNA therapeutics as well as vaccine platforms. I established a long-standing track record in lead identification and biomarker discovery work.

Working in the small-biotech environment, I embraced an entrepreneurial mindset and the necessity of wearing multiple hats across R&D, quickly adapting to an agile, fast-paced atmosphere to drive early-stage innovation. This hands-on approach and broad exposure to various functions, offered me a holistic view of the pipeline and the direct impact of my work. Transitioning to the corporate environment of a world-leading pharmaceutical company, I was able to utilize my diverse background while benefiting from the processes, resources, and expertise that define large organizations. In this highly impactful system, I was fortunate to lead and contributed to large-scale, international, high-priority projects with my work being instrumental to achieve set milestones.

As a consultant, I will be able to support activities across the full spectrum of the R&D pipeline, including, but not limited to:
• Identifying innovative new therapeutic concepts for immunological indications and pipeline expansion
• Developing mechanistic- and unmet-need-based research strategy to advance characterization of therapeutic targets and biomarkers
• Spearheading the development of novel in-vivo and ex-vivo animal and pathway models
• Supporting and guiding laboratory-based scientists in planning, execution and data analysis of in-vitro and in-vivo studies
• Bridging cross-functional/translational work with internal stakeholders as well as key external experts

KEY STRENGTH AND SKILLS
• Extensive expertise in early-to late-stage immunological research in the context of immuno-oncology and inflammation/autoimmunity
• Highly experienced in working cross functional within global project teams and with external partners/CROs
• Leadership experience by managing and mentoring teams and individual scientists
• Deep knowledge in cell- and molecular biology (with a vast array of in-vitro and in-vivo immune-bioassays), as well as characterization of disease relevant signaling pathways
• Extensive background in various animal models and multiple species
• Highly proficient in data analysis, -management, and -interpretation
• Excellent verbal and written communication- and presentation skills

Strategic Product Management/Marketing Leader with 25+ years of experience in life sciences, specializing in product management, new product development, developing global marketing strategy within the IVD, oncology, and infectious disease markets. Extensive experience leading multifunctional teams, building stakeholder relationships, and launching products involving advanced technologies, including NGS.

Over 35 years experience in life science research and the life science tools industry. 25+ years experience as a senior corporate executive in leading public and private life science tools companies, as well as board service and consulting over the past 10 years. A primary focus has been in corporate development and merger & acquisition.

Specialties: corporate development, merger and acquisition, and strategic planning in the life science tools industry

With over 25 years of leadership in the Life Sciences and Diagnostics market, I have built a proven track record of blending entrepreneurial vision with strategic business management expertise. Drawing from a wealth of experience across Business Development, R&D, Marketing, Sales, and Manufacturing, I have developed a deep technical foundation that drives a passion for revenue growth, market share expansion, and profit performance enhancement.

My leadership is defined by a commitment to innovation and a solution-oriented mindset, consistently helping businesses navigate complex challenges while fostering sustainable, high-impact partnerships across global markets.

Key Strengths:
• Building and scaling international distribution and sales channels
• Motivating and guiding teams to accelerate revenue growth
• Driving success in OEM and B2B sales strategies
• Leading contract negotiations, technology transactions, and licensing agreements
• Spearheading global business development across EMEA, APAC, LATAM, and Africa

By leveraging my expertise, global connections, and industry insights, companies can optimize their distribution networks, ensuring measurable results and maximizing revenue. With a focus on fine-tuning distribution strategies, together we can deliver sustainable growth across key regions.

As a strategic life sciences leader with over 14 years of experience in oncology, immuno-oncology, and cell and gene therapy, I am passionate about advancing innovative therapies that improve patient outcomes. My journey in biotech has been defined by a hands-on approach to discovery research, product development, and regulatory strategy, taking concepts from the lab bench to clinical trials.

Throughout my career, I’ve had the privilege of leading and contributing to groundbreaking projects. At TC BioPharm, I played a pivotal role in the FDA approval of an allogeneic gamma delta T cell therapy and the preclinical development of next-generation CAR-T products. My expertise in developing complex assays and driving exploratory clinical analyses has been critical in achieving key milestones, including advancing a phase 2/3 AML clinical trial.

As a consultant, I leverage my experience to guide biotech companies in refining development strategies and bridging preclinical and clinical efforts. From conducting due diligence for investments to streamlining development pathways, I provide actionable insights that reduce timelines and costs while maintaining scientific and regulatory rigour.
Collaboration is at the heart of this effort. I thrive in cross-functional teams, ensuring seamless integration across R&D, clinical, regulatory, and manufacturing functions. I also enjoy mentoring, developing talent, and fostering team innovation and resilience.

I actively contribute to the scientific community, having presented at international conferences such as the Gamma Delta T Cell Therapies Summit and the Allogeneic Cell Therapies Summit. My academic foundation, with a PhD in Medicine from the University of Glasgow, further underpins my technical expertise and commitment to translating research into impactful therapies.

Joining this network aligns with my drive to connect with like-minded professionals with a vision for transforming healthcare. I am eager to contribute my knowledge, learn from peers, and explore opportunities for collaboration that can accelerate therapeutic development and benefit patients worldwide.

With over a decade's experience in Life Sciences, Biotechnology Commercialization and Law, I have developed a broad scope of skills in various fields, ranging from sales and marketing, to regulatory and logistic affairs. During my time as business developer, I assisted companies in establishing global distribution networks, raised global awareness through marketing campaigns, and increased sales revenue three-fold within 18 months. I have substantial experience in biotech commercialization and have successfully overseen the commercial release of more than 80 products into the global market.

I specialize in assisting companies to develop and expand their business in South Africa and other African countries. This process entails the development and implementation of a commercial strategy that is tailored for the specific territory of interest, as well as the establishment of customer and distributor networks, and guidance as to regulatory compliance and logistic considerations. I have an aptitude for relationship building, strategic planning and target customer profiling, which forms the foundation of my business development capabilities.

A distinguished life science professional with over 33 years of extensive experience in research, leadership, and innovation, adeptly navigating the complexities of the biotech and life science sectors as the founder of LMF Biosciences and currently holding key executive positions at Biosensis Pty. Limited, Symansis Limited, as well as previous roles at EMD-Millipore and Chemicon. I have demonstrated exceptional prowess in driving organizational growth, developing strategic partnerships, and leading high-impact projects across various scientific disciplines from Cell Biology and Neuroscience to Molecular Biology, Cancer, and Metabolic Disease.
My career is highlighted by significant contributions to technical and customer service excellence, playing a pivotal role in the success of major companies like Millipore and Chemicon International. My expertise encompasses a wide range of technical skills, from the basics of immunohistochemistry and western blot, DNA/RNA manipulation, molecular cloning, and PCR to a comprehensive knowledge of cell culture techniques and protein analysis, making me a respected educator and trainer in the life science community.

With a solid track record of leading multi-person teams and directing technical service organizations, I have consistently delivered world-class service, support, and scientific assistance crucial to business success in the life science reagents sector. My strategic vision and innovative approach have been instrumental in product development, customer engagement, and identifying future growth areas, enabling companies to better anticipate and meet the diverse needs of their customers.

Beyond technical expertise, my leadership roles have showcased my ability to effectively manage and expand life science markets, achieving and surpassing sales targets while fostering sustainable growth. My entrepreneurial spirit, scientific understanding, and business insight make me an invaluable asset to any organization aiming to excel in the competitive biotech and life science research reagents landscape.

In summary, I offer a unique blend of scientific excellence, strategic business management, and visionary leadership, making me an ideal candidate for roles that demand depth of knowledge, innovative thinking, and a proven track record of success in the life sciences sector.

Marketing and communications leader with extensive agency and manufacturer side experience in sectors including Life Sciences and Consumer Packaged Goods. Proven track record leading strategic vision, delivering executional excellence and cultivating teams in the areas of media, digital marketing, consumer promotions, PR, agency relations, creative services and package design.
Leveraging decades of corporate experience to help companies, both large and small, elevate their marketing communication practices by providing 1) interim strategic leadership and executional oversight, 2) evaluating and optimizing organizational structure and practices and 3) assessing talent.
Recent engagements have included: 1) leading global marketing initiatives targeted to the recombinant protein scientific community including collateral development, global adaptations, email marketing. This required creating structure and education around goal setting, measurement and reporting; 2) Acting as the interim head of integrating communications for mid-sized nutritional company in need of reevaluating the structure of their Package Design and Media functions which consisted of 35 subject matter experts.
QUALIFICATIONS AND SKILLS
● Integrated Marketing
● Operational Efficiencies
● Agency Selection/Management
● Omnichannel Planning & Buying
● Talent Development
● Executive Recruiting
● Consumer Relations
● Change Management
● Marketing Content Development
● Organization Design
● Zero-based Budgeting
● Public Relations

I consider myself an "all-rounder," but as a consultant, I focus on helping clients with their marketing, bringing my experience from the last 25 years working in a range of commercial roles at top life science companies. After a Ph.D. and post-docs, I started my first non-lab role in tech support, then developed my business skills in sales and business development before progressing to senior management positions in marketing, product management, and business unit management, where I founded and led international teams.

I've worked with commercial and technical teams at >200 life science companies - distributors, manufacturers, and OEM resellers in public companies, private companies, and startups. As a consultant, I take on a range of commercial projects, mainly in the marketing/product management realm, specializing in writing engaging content to attract and convert customers, including websites and sales tools.

Innovator with extensive experience and a proven track record of developing successful corporate strategies that increase revenues in the Life Sciences industry. Creative visionary and change agent who identifies growth markets, business drivers and builds collaborative global and cross-functional relationships. Recognized for combining transformational business strategies with supporting business cases, operating plans, budgets, and programs.
EXPERTISE
Strategic Planning | M&A | Financial Analysis | Partnerships and IVs | Market Assessments | Negotiation | Deal Structuring | Due Diligence
APPLICATIONS
Flow cytometry, antibodies, reagents, dyes, instruments ( sorters and analyzers)

Senior technical expertise on antibodies and immunoassays

With a thorough background of molecular cell biology and biochemistry, I have accrued multi-disciplinary knowledge and experience while working in both academic and commercial environments with an emphasis on antibodies and immunoassays. During my CSO appointment at an antibody manufacturer, I have gained global recognition on my knowledge of commercial antibodies and their validation through meetings and publications. During my time involving drugs discovery I have developed several assays and filed for patents. I have tutored and trained assistants to very high standard, and many of them have moved on the career ladder since then. After I have written SOPs in a GLP-audited CRO and many technical and managerial SOPs for a fast-growing research antibody manufacturer, my focus has been on protein biomarkers and antibody validation to industrial standard. This focus led to a thorough understanding of etiologies at protein level and of diagnostics and medical interventions. My understanding of physical, chemical, and pharmacological principles made me ready to move on as an independent consultant to aid antibody manufacturers and in vitro diagnostics industries. My interest in strategic planning has helped me thinking creatively thus providing valuable inspirations to move biotech/pharma companies forward.
Based on the above, I was in the opportunity to set up my own company to introduce a long sought after quality standard for commercial tool antibodies. This concept may ultimately also work for the early discovery of candidate therapeutic antibodies.
My expertise is now available to assist in technical or strategic hurdles when complementary experience is required. When assistance is needed for a start-up or for a well-established company, confidentiality is guaranteed, and NDAs can be exchanged when required.

30+ years of experience in the Life Sciences Industry, with particular expertise in research tools including antibodies, recombinant proteins and associated kits.
I have a PhD in Immunology, and commercial experience at Board level as Site Director, Commercial Director and Chairman. I have worked with family businesses, listed companies and PE backed companies, and have experience of developing companies to successful trade exits. My focus within industry has always been to identify new opportunities with either technology or with customers, and to execute those as quickly and effectively as possible.
Commercially I have gained in depth experience in a range of roles, and can offer advice in Business Development, Strategy, Operational and Technical areas My in-depth experience includes:-

Business Strategy
Reagent in-licensing and out-licensing
Supply agreements
Business development with major IVD and Pharmaceutical customers
Product development
P&L analysis and responsibility
Quality Systems
Developing and leading Commercial Sales and Marketing teams
Operational expertise and commercial reagent manufacturing

Having worked, as a VP and MD in the recombinant protein industry for 29+ years I have set up and run European legal entities and operations for a North American based business. I have identified and developed target markets and clients, establishing and growing the customer base, distribution channels and market share across multiple territories, including Europe, China and Japan, as well as guiding and shaping policy and direction from the North American Headquarters.
I have experience of setting up and developing individual and group management structures, of managing regional companies’ P&L, and of identifying and rolling out KPI’s, in alignment with corporate growth and direction. The responsibility and development of internal and external brand proposition and corporate communications, developing Go To Market strategies and delivery, as well as the overall marketing concepts have formed a core element of my experience.
I oversaw the strategic and business elements of the transition from RUO arena to that of GMP, working closely alongside the manufacturing and regulatory team.
Having served on the global Board and executive team, I have created and led teams across multiple job functions and markets. In addition I acted as an integral senior team member preparing a multinational business for sale, as I worked on the due diligence of the acquisition, as well as providing support and guidance for the early stages of post transaction integration.
My aim as a consultant and as a mentor is to bring knowledge, experience, skills, support, and hopefully reassurance, to help others develop and build their brands, teams, and businesses.

Having worked as a product and commercial manager for 18 years within the life science industry, my focus was always to identify cutting edge technology, applications and novel scientific companies, working with them to present their products to the wider research and IVD markets. With a skillset focused on bringing novel technologies to new markets and working to build diverse, integrated portfolios for platforms, my experience, combined with my scientific knowledge, placed me well to work within Mergers & Acquisitions on both buy side and sell side transactions along with strategic pieces.
Specialities: Biotech & Life science Consultancy, specialising in Business Development, strategy and M&A assistance.
Specialises in understanding how the scientific capabilities of companies can be presented to the life science customer base or utilised to build upon strengths of platforms for inorganic expansion.

40 years of experience working in the Research Tools industry, with focus on commercialization of Antibodies, Proteins and Assays. Have founded and ran my own businesses in the RUO area and successfully exited. Have also invested minority stakes in several RUO companies and sat on various Boards as an NED. Previously worked at Serotec for 25 years, then sat on Boards such as Innova Biosciences, Absolute Antibodies, Medix Biochemica, Cellexus & Oxford Expression Technologies.
Experience in setting up and implementing Distribution channels, marketing plans and full business plans. Helped companies exit.
Specialties: Biotech & Lifescience Consultancy, specialising in Business Development and M&A assistance.
Specialises in matching lifescience business partners (finding distributors & OEM Partners)